Key outcome measures included hemoglobin A1c levels, glucose tolerance, insulin secretion, and progression to type 2 diabetes postpartum.<h4>Results</h4>GLP-1 receptor agonists effectively manage blood glucose and reduce pregnancy complications associated with GDM. The gene discussed is INS; the disease is gestational diabetes.